S&P affirms ratings on Bemis (BMS); outlook lowered from Positive to Stable
- Gilead (GILD) Tanks; Analyst Comments on Express Scripts (ESRX) Viekira Pak Announcement (ABBV)
- Steelcase Inc. (SCS) Tops Q3 EPS by 3c, Offers Guidance
- Twitter (TWTR) Active on Renewed Dick Costolo Chatter
- Achillion Pharma (ACHN) Reports 4.8 Log10 Reduction With ACH-3422
- UPDATE: Bristol-Myers Squibb (BMY): Nivolumab Cleared by FDA for Advanced Melanoma
S&P affirms ratings on Bemis (NYSE: BMS); outlook lowered from Positive to Stable
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ukraine Cut to 'CCC-' by S&P, Outlook Negative (FXE) (UUP)
- Moody's Affirms Ratings, Outlook on Ocwen (OCN), Altisource Solutions (ASPS), HLSS (HLSS)
- Tekmira Pharma (TKMR) PT Cut to $21 at Maxim Group; 'Buy' Maintained
Create E-mail Alert Related CategoriesCredit Ratings
Related EntitiesStandard & Poor's
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!